✦ LIBER ✦

PSS23 COST-EFFECTIVENESS ANALYSIS OF IMIQUIMOD VERSUS NO TREATMENT IN ACTINIC KERATOSES

✍ Scribed by Walczak, J; Nogas, G; Dybek-Karpiuk, A; Kloc, K; Labak, M; Pawlik, D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN46 COST-EFFECTIVENESS ANALYSIS OF IMI

✍ Walczak, J; Nogas, G; Dybek-Karpiuk, A; Kloc, K; Labak, M; Pawlik, D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCN99 COST-EFFECTIVENESS ANALYSIS OF IMI

✍ J Walczak; G Nogas; A Dybek-Karpiuk; K Kloc; M Labak; D Pawlik 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB

PMH28 COST-EFFECTIVENESS ANALYSIS OF ZIP

✍ JR Azanza; M Bernardo; C Rubio-Terrés; V Diez; J Rejas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Vaccination versus treatment of influenz

✍ Michael B. Rothberg; David N. Rose 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 189 KB

PCN23 COST-EFFECTIVENESS ANALYSIS OF LAP

✍ F Ejzykowicz; JW Hay 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

PSN2 COST-EFFECTIVENESS ANALYSIS: ALDARA

✍ JM Sverre; FKO Kristensen; L Hamel-Gariépy; T Albrektsen 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB